- Joined
- Oct 29, 2002
- Messages
- 10
- Reaction score
- 0
In a forum in 8/03, the "top tier" path programs were subjectively stated by one person to be the following, in no particular order:
Brigham
MGH
U Washington
Stanford
Mayo
UCLA
Emory
Duke
UTSW
UCSF
Overall I agree with this, but I think Hopkins should be added to this list.
I am wondering what the current thinking on this is...for instance, people rave about Michigan, UVA, Cleveland Clinic, Columbia, UNC, Pittsburgh and U Penn...
First of all, I am wondering what criteria people use when they consider "top tier" programs...reputation? research money? overall quality of the hospital? pathology publications?--because frankly, many of these criteria may not improve resident training. In fact, many (but definitely not all) of these so-called "top tier" programs are also said to be "malignant"--with insane work hours, endless scutwork, and a quality of life so poor that it borders on that of our clinical intern brethren. I know--duh!--but some newbies to the path forum may not be aware of these differences in quality of training.
It makes me wonder...what is the current thinking on these "top tier" programs? And which of these programs would be considered "benign" vs. "malignant"? Are more benign, "middle tier" programs gaining more respect based on quality of training rather than reputation--and what about the programs with a "big name" reputation?
I hear so many different ideas from everyone. But what the hey--let's hash it out--we may be able to offer insight at least to people who will be applying next year
Brigham
MGH
U Washington
Stanford
Mayo
UCLA
Emory
Duke
UTSW
UCSF
Overall I agree with this, but I think Hopkins should be added to this list.
I am wondering what the current thinking on this is...for instance, people rave about Michigan, UVA, Cleveland Clinic, Columbia, UNC, Pittsburgh and U Penn...
First of all, I am wondering what criteria people use when they consider "top tier" programs...reputation? research money? overall quality of the hospital? pathology publications?--because frankly, many of these criteria may not improve resident training. In fact, many (but definitely not all) of these so-called "top tier" programs are also said to be "malignant"--with insane work hours, endless scutwork, and a quality of life so poor that it borders on that of our clinical intern brethren. I know--duh!--but some newbies to the path forum may not be aware of these differences in quality of training.
It makes me wonder...what is the current thinking on these "top tier" programs? And which of these programs would be considered "benign" vs. "malignant"? Are more benign, "middle tier" programs gaining more respect based on quality of training rather than reputation--and what about the programs with a "big name" reputation?
I hear so many different ideas from everyone. But what the hey--let's hash it out--we may be able to offer insight at least to people who will be applying next year